BR31: A phase 3, double blind, placebo controlled, randomised trial of adjuvant durvalumab in completely resected non-small cell lung cancer

被引：0
|
作者：
McLachlan, Sue-Anne [1 ,2 ]
Mersiades, Antony [3 ]
Wright, Gavin [4 ]
Millward, Michael [5 ]
Goss, Glenwood [6 ]
Darling, Gail [7 ,8 ]
Jurkovic, Hannora [3 ]
Bradley, Ann-Marie [9 ]
Pavlakis, Nick [10 ]
Blinman, Prunella [11 ,12 ]
Ding, Keyue [13 ]
O'Callaghan, Chris [9 ,14 ]
Stockler, Martin [3 ]
机构：
[1] St Vincents Hosp, Dept Med Oncol, Melbourne, Vic, Australia
[2] Univ Melbourne, Melbourne, Vic, Australia
[3] Univ Sydney, NHMRC Clin Trials Ctr, Camperdown, NSW, Australia
[4] St Vincents Hosp, Dept Surg, Melbourne, Vic, Australia
[5] Sir Charles Gairdner Hosp, Dept Med Oncol, Perth, WA, Australia
[6] Ottawa Hosp, Res Inst, Ctr Canc Therapeut, Ottawa, ON, Canada
[7] Toronto Gen Hosp, Univ Hlth Network, Div Thorac Surg, Dept Surg, Toronto, ON, Canada
[8] Univ Toronto, Toronto, ON, Canada
[9] Queens Univ, Canadian Canc Trials Grp, Kingston, ON, Canada
[10] Royal North Shore Hosp, Dept Med Oncol, Sydney, NSW, Australia
[11] Concord Canc Ctr, Dept Med Oncol, Sydney, NSW, Australia
[12] Univ Sydney, Sydney, NSW, Australia
[13] Queens Univ, Canc Res Inst, Canadian Canc Trials Grp, Kingston, ON, Canada
[14] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
419
引用
收藏
页码：198 / 199
页数：2
相关论文
共 50 条
  • [41] Is there a role for adjuvant therapy for resected non-small cell lung cancer?
    Jett, JR
    THORAX, 1999, 54 : S37 - S41
  • [42] Adjuvant chemotherapy for surgically resected non-small cell lung cancer
    Heon, Stephanie
    Johnson, Bruce E.
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2012, 144 (03): : S39 - S42
  • [43] Pembrolizumab versus placebo as adjuvant therapy for completely resected stage IB-IIIA non-small-cell lung cancer (PEARLS/KEYNOTE-091): an interim analysis of a randomised, triple-blind, phase 3 trial
    O'Brien, Mary
    Paz-Ares, Luis
    Marreaud, Sandrine
    Dafni, Urania
    Oselin, Kersti
    Havel, Libor
    Esteban, Emilio
    Isla, Dolores
    Martinez-Marti, Alex
    Faehling, Martin
    Tsuboi, Masahiro
    Lee, Jong-Seok
    Nakagawa, Kazuhiko
    Yang, Jing
    Samkari, Ayman
    Keller, Steven M.
    Mauer, Murielle
    Jha, Nitish
    Stahel, Rolf
    Besse, Benjamin
    Peters, Solange
    LANCET ONCOLOGY, 2022, 23 (10): : 1274 - 1286
  • [44] The future of adjuvant chemotherapy for resected non-small cell lung cancer
    Vansteenkiste, JF
    Schildermans, RH
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (01) : 165 - 175
  • [45] A phase III randomised, double blind, placebo controlled trial of etoposide/carboplatin with or without thalidomide in advanced small cell lung cancer (SCLC)
    Lee, Siow-Ming
    Woll, Penella J.
    James, Lindsay E.
    Hatton, Matthew
    Ali, Kulsam
    Spiro, Stephen G.
    Ali, Sumrana R.
    Hackshaw, Allan
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (08) : S306 - S307
  • [46] Efficacy of adjuvant chemotherapy for completely resected stage IB non-small cell lung cancer: a retrospective study
    Park, Hye Jung
    Park, Heae Surng
    Cha, Yoon Jin
    Lee, Sungsoo
    Jeung, Hei-Cheul
    Cho, Jae Yong
    Kim, Hyung Jung
    Byun, Min Kwang
    JOURNAL OF THORACIC DISEASE, 2018, 10 (04) : 2279 - 2287
  • [47] Adjuvant chemotherapy for completely resected non-small-cell lung cancer.
    Greco, FA
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (09): : 689 - 689
  • [48] Adjuvant chemotherapy in completely resected stage III-N2 non-small cell lung cancer
    Wang, S.
    Ou, W.
    Sun, H.
    Yang, H.
    Ye, X.
    Fang, Q.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [49] Double blind, placebo controlled trial of oral lactoferrin in combination therapy for first line non-small cell lung cancer (NSCLC).
    Wang, Y
    Yankee, E
    Varadhachary, A
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 655S - 655S
  • [50] Review of practice patterns for adjuvant chemotherapy in patients with completely resected non-small cell lung cancer (NSCLC)
    Visbal, A
    Kassam, F
    Johnston, M
    Feld, R
    Shepherd, F
    Darling, G
    Keshavjee, S
    Pierre, A
    Waddell, T
    Leighl, N
    LUNG CANCER, 2005, 49 : S97 - S97
12345